2009
DOI: 10.1007/s11095-009-9831-4
|View full text |Cite
|
Sign up to set email alerts
|

In Silico Prediction of Drug Permeability Across Buccal Mucosa

Abstract: A simple model was developed and validated for predicting the buccal drug permeability. This model will be useful in assessing the feasibility of drugs for transbuccal delivery.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
15
0
1

Year Published

2011
2011
2020
2020

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 44 publications
(18 citation statements)
references
References 48 publications
1
15
0
1
Order By: Relevance
“…However, HBD negatively affects CL re values (eq. 7), consistent with previous observations that hydrogen bond donors decrease the permeability of the cell membrane due to increased interactions with the lipid bilayer (Winiwarter et al, 1998;Kokate et al, 2009). Given that CL sec and CL re values were almost identical for many drugs (Fig.…”
Section: Prediction Of Drug Transfer Into Human Milksupporting
confidence: 90%
“…However, HBD negatively affects CL re values (eq. 7), consistent with previous observations that hydrogen bond donors decrease the permeability of the cell membrane due to increased interactions with the lipid bilayer (Winiwarter et al, 1998;Kokate et al, 2009). Given that CL sec and CL re values were almost identical for many drugs (Fig.…”
Section: Prediction Of Drug Transfer Into Human Milksupporting
confidence: 90%
“…In general, drug permeability across biomembranes, including the skin, increases with increasing permeant lipophilicity and decreases with increasing molecular size [23][24][25][26]. It is, therefore perhaps, not surprising that both log P and MW appear in the empirical relation describing drug clearance from the skin.…”
Section: Resultsmentioning
confidence: 99%
“…This family mainly includes ibuprofen (IBU), naproxen (NAP) and ketoprofen (KPF) whose consumption in Spain , was close to 99% of total PROs between the years 2000–2012, representing 33–65% of total NSAIDs. The abbreviated name of each of the three above mentioned PROs and their enantiomers, CAS Registry Number, IUPAC name and chemical structure can be found in Table . The main accepted PRO pharmacological properties are analgesic, anti‐inflammatory and antipyretic, depending on their enantiomeric form , which is usually distinguished by biological systems.…”
Section: Introductionmentioning
confidence: 99%